Page 4«..3456..1020..»

Category : Nanomedicine

May 2020 Global Radiocontrast Agent Market Report 2020 COVID 19 Impact Analysis on Key Players GE Healthcare (US), Bracco Imaging (Italy), Bayer…

The research report on the Radiocontrast Agent market provides a detailed analysis of the market. A detailed analysis of the market is done by covering all the major aspects, which affects the growth of the market. The report on Radiocontrast Agent market also provides a detailed impact of the current trends, such as the corona virus pandemic (COVID-19).

Inquiry For Buying or Customization of Report: @ https://www.cognitivemarketresearch.com/chemical-%26-materials/radiocontrast-agent-market-report#request_sample

Global Radiocontrast Agent market report offers in-depth insights of the supply chain and the strategies for the growth of the Radiocontrast Agent market. The impact of the corona virus on the supply chain is also covered, which is one of the major attributes which affects the Radiocontrast Agent market. The market report on Radiocontrast Agent market also covers a detailed analysis of the growth and the impact of the products which were introduced before the impact of the COVID-19 pandemic. A detailed analysis of the product life cycle is also covered in the Radiocontrast Agent market report. nicolas.shaw@cognitivemarketresearch.com or call us on +1-312-376-8303.

Request a Sample Copy of this report @ https://www.cognitivemarketresearch.com/chemical-%26-materials/radiocontrast-agent-market-report#request_sample

Market Segmentation:Segmentation by Type: Barium-based Radiocontrast Agent, Iodinated Radiocontrast Agent, Gadolinium-based Radiocontrast Agent, Microbubble Radiocontrast Agent, X-ray/Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound

Segmentation by Application: Radiology, Interventional Radiology, Interventional Cardiology

Segmentation by Key Players:b> GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), Guerbet (France), Lantheus (US), Daiichi Sankyo (Japan), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals (India), Spago Nanomedicine (Sweden), Taejoon Pharm (South Korea), Jodas (India), Magnus Health (India)

Download and Access Exclusive Free Sample Report Pages {CoronoVirus Impact Analysis Updated Copy} Click Here> Download Sample Report of Radiocontrast Agent Market Report 2020 (Updated Eidtion May 2020)

Market, By Regions:In addition, Radiocontrast Agent market report categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period. Following are the regions we covered in this report:North America (the United States, Canada, and Mexico)Europe (Germany, UK, France, Italy, and Russia, etc.)Asia-Pacific (China, Japan, ASEAN, India, and Korea)The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)South America (Brazil, Chile, Peru, and Argentina)

Table of Content : Global Radiocontrast Agent Market Report 2019: Market Size, Status and Forecast Till 2027 Chapter 1. Industry Overview of Global Radiocontrast Agent Chapter 2 Global Radiocontrast Agent Competition Analysis by Players Chapter 3 Company (Top Players) Profiles Chapter 4 Global Radiocontrast Agent Market Size by Type and Application (2014-2019) Chapter 5 Development Status and Outlook Chapter 11 Market Forecast by Regions, Type and Application (2019-2027) Chapter 12 Global Radiocontrast Agent Market Dynamics Chapter 12.1 Global Radiocontrast Agent Industry News 12.2 Global Radiocontrast Agent Industry Development Challenges 12.3 Global Radiocontrast Agent Industry Development Opportunities (2019-2027) Chapter 13 Market Effect Factors Analysis Chapter 14 Global Radiocontrast Agent Market Forecast (2019-2027) Chapter 15 Research Finding/Conclusion Chapter 16 Appendix To check the complete Table of Content click here: @ https://www.cognitivemarketresearch.com/chemical-%26-materials/radiocontrast-agent-market-report#table_of_contents

Thanks for reading this article; Please connect with our sales team, who will ensure that you get a report that suits your needs.

Inquiry For Buying or Customization of Report: @ https://www.cognitivemarketresearch.com/chemical-%26-materials/radiocontrast-agent-market-report#request_sample

About us: http://www.cognitivemarketresearch.com/about-usNicolas Shaw,Sales Manager,Global Business Development,Website: http://www.cognitivemarketresearch.comEmail: nicolas.shaw@cognitivemarketresearch.com or call us on +1-312-376-8303.Address: 20 N State Street, Chicago, Illinois, 60602, United States.

**********Download the Entire Report*************************************************

Read the original:
May 2020 Global Radiocontrast Agent Market Report 2020 COVID 19 Impact Analysis on Key Players GE Healthcare (US), Bracco Imaging (Italy), Bayer...

Recommendation and review posted by Alexandra Lee Anderson

Global Nanorobotics Market : Industry Analysis and Forecast (2019-2026) by Type, Application, and… – Azizsalon News

Global Nanorobotics Marketwas valued at US$ 3.7 Bn in 2018 and is expected to reach US$ 9.2Bn by 2026, at a CAGR of 12.06%during a forecast period.

Developments in nanotechnology coupled with demand for minimally aggressive procedures are expected to drive market growth over the forecast period. Nanobots possess likely in the medical sector for destroying cancerous cells at the genetic level. Increasing support for nanomedicine by many nations and the increasing geriatric population are factors which can augur market demand.

REQUEST FOR FREE SAMPLE REPORT:https://www.maximizemarketresearch.com/request-sample/30888

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Utilization of nanobots in the ranostics can be beneficial for the market in the near future. A rise in miniaturization and demand for automation across various sectors are anticipated to fuel market growth. Training of new personnel to use nanobots can restrain market growth in the upcoming years.Nanomedicine application segment to grow at the highest CAGR during the forecast period. Nanorobotics is widely used in nanomedicine owning to its healthcare features. The large share of this application aspects to the large level of commercialization in the healthcare sector for drug delivery, in vivo imaging, biomaterial, in vitro diagnostic, active implants, and drug therapy.

North America region accounted for the largest share of 12.2%, in terms of value, of the nanorobotics market globally. Presence of many nanotechnology companies, well-developed healthcare infrastructure, and government initiatives to create patient awareness are factors driving the market. The U.S is anticipated to contribute to market revenue owing to the increase in cardiovascular diseases and the rising elderly populace.

Europe follows North America as the second biggest nanorobotics market. Presence of chronic diseases and the burgeoning population are factors expected to indicate the Europe nanobots market. Establishment of organizations to develop standards pertaining to nanotechnology can expand market growth. In 2018, DNA-Robotics, an organization including 12 European companies, has outlined steps to expedite production of nanobots on a large scale. These standards can help scale the market exponentially in the upcoming years.

A recent development in nanorobotics market: In March 2018, Thermo Fisher Scientific acquired Gatan, an exclusively owned subsidiary of Roper Technologies. Gatan is an electron microscopy solutions provider in the U.S, which accompaniments the Thermo Fisher Scientifics electron microscopy solutions business.In March 2017, Oxford Instruments (U.K) Asylum Research introduced its new SurfRider HQ-Series of high quality, budget-priced AFM probes, which are also existing in a model suitable for nanomechanical image mode.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Nanorobotics Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTERs analysis, SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the Global Nanorobotics Market.

DO INQUIRY BEFORE PURCHASING REPORT HERE:https://www.maximizemarketresearch.com/inquiry-before-buying/30888

Scope of the Global Nanorobotics Market

Global Nanorobotics Market, By Type

Nanomanipulatoro Electron Microscope (EM) Scanning Electron Microscope (SEM) Transmission Electron Microscope (TEM)o Scanning Probe Microscope (SPM) Atomic Force Microscopes (AFM) Scanning Tunneling Microscope (STM) Bio-Nanorobotics Magnetically Guided Bacteria-BasedGlobal Nanorobotics Market, By Application

Nanomedicine Biomedical Mechanical OthersGlobal Nanorobotics Market, By Region

North America Europe Asia Pacific Middle East and Africa South AmericaKey players operating in Global Nanorobotics Market:

Bruker JEOL Thermo Fisher Scientific Ginkgo Bioworks Oxford Instruments EV Group Imina Technologies Toronto Nano Instrumentation KlockeNanotechnik KleindiekNanotechnik Xidex Synthace Park Systems Smaract Nanonics ImagingKey Innovators:

Novascan Technologies Angstrom Advanced Hummingbird Scientific NT-MDT Spectrum Instruments Witec

MAJOR TOC OF THE REPORT

Chapter One: Nanorobotics Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Nanorobotics Market Competition, by Players

Chapter Four: Global Nanorobotics Market Size by Regions

Chapter Five: North America Nanorobotics Revenue by Countries

Chapter Six: Europe Nanorobotics Revenue by Countries

Chapter Seven: Asia-Pacific Nanorobotics Revenue by Countries

Chapter Eight: South America Nanorobotics Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Nanorobotics by Countries

Chapter Ten: Global Nanorobotics Market Segment by Type

Chapter Eleven: Global Nanorobotics Market Segment by Application

Chapter Twelve: Global Nanorobotics Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Nanorobotics Market Report at:https://www.maximizemarketresearch.com/market-report/global-nanorobotics-market/30888/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website:www.maximizemarketresearch.com

Read more here:
Global Nanorobotics Market : Industry Analysis and Forecast (2019-2026) by Type, Application, and... - Azizsalon News

Recommendation and review posted by Alexandra Lee Anderson

Nanoparticle antivirals offer new way to fight coronaviruses but therapy is still in its infancy – Chemistry World

The unfolding Sars-2-CoV outbreak is laying bare the worlds need for effective antivirals. According to University of Lille chemist Sabine Szunerits, we should invest in this now, knowing that viruses will be an issue in the 21st century. With this in mind she and collaborators at the Pasteur Institute in Lille, France have, over the past few years, been developing a new approach to tackling viruses including coronaviruses that takes advantage of the unique properties of nanoparticles.

There are only a handful of approved antiviral treatments and these are only effective against a few specific viruses. This means that when new viral diseases like Covid-19 emerge doctors are left trying to repurpose existing antivirals in the hope that they will have an effect on the new disease.

Viruses are not technically alive, they are packages of RNA or DNA that can only replicate by hijacking its hosts genetic machinery. Antivirals do not destroy these packages, they are small molecules designed to block viral replication, thereby reducing symptoms and infectivity while the immune system deals with them. Unfortunately, because viruses rely on the hosts DNA replication machinery finding drugs that only target and bind specific virus proteins and not those of the host cell is a challenge. This lack of specificity means large doses of antivirals are often needed to achieve the desired effect, which in turn increases toxicity.

The field of nanomedicine, however, has been exploring how nanoparticles can overcome some of these problems. The promise of nanoparticle antivirals comes from their multivalency the number of interactions occurring as molecules bind together. The nanoparticle of choice for Szunerits are carbon quantum dots (CQDs) which are spherical, have a high surface-to-volume ratio and are smaller in size than viruses creating conditions where multivalent interactions can play a role. The surface of the CQDs can also be coated with molecules that bind the proteins viruses use to enter cells. The spherical shape and smaller size of the CQD mean these molecules can form extremely tight multivalent bonds with proteins all over the viruss surface, blocking it from attaching to and infecting a host cell. Szunerits and team started this work in 2018, testing the ability of CQDs with boronic acid groups to reduce the infectivity of a mild strain of human coronaviruses in cell lines.They achieved significant reductions in viral entry relative to controls and are now working on CQDs coated with Middle East Respiratory Syndrome (MERS) specific peptides, showing that CQDs should be able to be adapted to specific viral threats.

Cameron Alexander at the University of Nottingham, who works with nanoparticle-based RNA vaccines sees the potential adaptability of this type approach. Once youve got a nanoparticle with the right spacing and chemical functionalities to match one virus, its not inconceivable to think how you could plug and play different groups on that surface to find another virus.

Igor Medintz, a senior scientist with the US Naval Research Laboratory in Washington DC, agrees that the plug and play nature of this approach is promising because, as long as a molecule is biocompatible, there are few limitations to the options available. Theres a huge library of non-natural amino acids that can be accessed as well you can synthesise peptides with just about any chemical or functional group possible and those could give them very high binding affinity beyond the naturally occurring ones, he says.

Another drawback of current antivirals is that they are often insoluble making administering them more difficult. Often drugs on the market are rather hydrophobic and the pharma industry always likes delivering drugs orally, says Szunerits. Nanoparticles like CQDs are hydrophilic, however, allowing them to circulate better. Due to their size, they are also easier to deliver as a fine spray, which for infections that affect the lungs, such as coronaviruses, would be more effective.

Right now, Szunerits and the team are experimenting with liposome packages to deliver CQDs, as well as assessing the big question of how the body will handle them once theyve serve their function. Early studies by her group have shown that CQDs injected into mice are passed in urine, which along with in vitro toxicity studies provide hopeful signs that the body can tolerate them.

As with any new treatment moving from the lab to clinical trials and then scaling-up production is a long road. According to Alexander, making these types of particles is easy enough but ensuring uniformity in large batches required for a therapeutic becomes problematic. When youre making some of these systems, you need to check that the size is correct, the functionality is correct and the more functionality you put in it, the more complicated they are to characterise, he says. The more complicated to characterise, the harder it is to get regulatory approval, and the harder it is to manufacture.

Visit link:
Nanoparticle antivirals offer new way to fight coronaviruses but therapy is still in its infancy - Chemistry World

Recommendation and review posted by Alexandra Lee Anderson

Healthcare Nanotechnology (Nanomedicine) Market Development, Trends, Key Driven Factors, Segmentation And Forecast to 2020-2026 – Cole of Duty

Other

The report is a compilation of different studies, including regional analysis where leading regional Healthcare Nanotechnology (Nanomedicine) markets are comprehensive studied by market experts. Both developed and developing regions and countries are covered in the report for a 360-degree geographic analysis of the Healthcare Nanotechnology (Nanomedicine) market. The regional analysis section helps readers to become familiar with the growth patterns of important regional Healthcare Nanotechnology (Nanomedicine) markets. It also provides information on lucrative opportunities available in key regional Healthcare Nanotechnology (Nanomedicine) markets.

Ask For Discounts, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=210503&utm_source=COD&utm_medium=888

Table of Content

1 Introduction of Healthcare Nanotechnology (Nanomedicine) Market

1.1 Overview of the Market1.2 Scope of Report1.3 Assumptions

2 Executive Summary

3 Research Methodology

3.1 Data Mining3.2 Validation3.3 Primary Interviews3.4 List of Data Sources

4 Healthcare Nanotechnology (Nanomedicine) Market Outlook

4.1 Overview4.2 Market Dynamics4.2.1 Drivers4.2.2 Restraints4.2.3 Opportunities4.3 Porters Five Force Model4.4 Value Chain Analysis

5 Healthcare Nanotechnology (Nanomedicine) Market, By Deployment Model

5.1 Overview

6 Healthcare Nanotechnology (Nanomedicine) Market, By Solution

6.1 Overview

7 Healthcare Nanotechnology (Nanomedicine) Market, By Vertical

7.1 Overview

8 Healthcare Nanotechnology (Nanomedicine) Market, By Geography

8.1 Overview8.2 North America8.2.1 U.S.8.2.2 Canada8.2.3 Mexico8.3 Europe8.3.1 Germany8.3.2 U.K.8.3.3 France8.3.4 Rest of Europe8.4 Asia Pacific8.4.1 China8.4.2 Japan8.4.3 India8.4.4 Rest of Asia Pacific8.5 Rest of the World8.5.1 Latin America8.5.2 Middle East

9 Healthcare Nanotechnology (Nanomedicine) Market Competitive Landscape

9.1 Overview9.2 Company Market Ranking9.3 Key Development Strategies

10 Company Profiles

10.1.1 Overview10.1.2 Financial Performance10.1.3 Product Outlook10.1.4 Key Developments

11 Appendix

11.1 Related Research

Get Complete Report

@ https://www.marketresearchintellect.com/need-customization/?rid=210503&utm_source=COD&utm_medium=888

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Tags: Healthcare Nanotechnology (Nanomedicine) Market Size, Healthcare Nanotechnology (Nanomedicine) Market Trends, Healthcare Nanotechnology (Nanomedicine) Market Growth, Healthcare Nanotechnology (Nanomedicine) Market Forecast, Healthcare Nanotechnology (Nanomedicine) Market Analysis Sarkari result, Government Jobs, Sarkari naukri, NMK, Majhi Naukri,

Here is the original post:
Healthcare Nanotechnology (Nanomedicine) Market Development, Trends, Key Driven Factors, Segmentation And Forecast to 2020-2026 - Cole of Duty

Recommendation and review posted by Alexandra Lee Anderson

(IMPACT OF COVID-19) Nanomedicine Market Research 2020 Next Big Thing | GE Healthcare, Johnson& Johnson, Mallinckrodt plc, Merck& Co. Inc.,…

Global Nanomedicine Market 2020-2027

GlobalNanomedicine Market Global Drivers, Restraints, Opportunities, Trends, and Forecasts up to 2027. Market Over viewing the present digitized world, 80% of the data generated is unstructured. Organizations are usingNanomedicine technology to unravel the meaning of such data to leverage business strategies and opportunities. A myriad of unstructured data is available online in the form of audio content, visual content and social footprints.

The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2020-2027.The Report scope furnishes with vital statistics about the current market status and manufacturers. It analyzes the in-depth business by considering different aspects, direction for companies, and strategy in the industry.

Our new sample is updated which correspond in new report showing impact of COVID-19 on Industry

The Key Players Profiled In the Market Include

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.)

The Key Players | * GE Healthcare, * Johnson& Johnson, * Mallinckrodt plc, * Merck& Co. Inc., * Nanosphere Inc., and * Pfizer Inc.

For Better Understanding, Download Sample PDF Copy of Nanomedicine Market Research Report @

After analyzing the report and all the aspects of the new investment projects, it is assessed the overall research and closure offered. The analysis of each segment in-detailed with various point views; that include the availability of data, facts, and figures, past performance, trends, and way of approaching in the market.The progressive growth in Nanomedicine Market report also covers the in-depth analysis of the market dynamics, price, and forecast parameters which also include the demand, profit margin, supply and cost for the industry.

Key question and answered in the report include:

What will the market size and the growth rate be in 2027?

What are the key factors driving the GlobalNanomedicine Market?

What are the key market trends impacting the growth of the GlobalNanomedicine Market?

What are the challenges to market growth?

Who are the key North vendors in the GlobalNanomedicine Market?

What are the market opportunities and threats faced by the vendors in the GlobalNanomedicine Market?

This report provides pinpoint analysis for changing competitive dynamics. It offers a forward-looking perspective on different factors driving or limiting market growth. It provides a five-year forecast assessed on the basis of how they progressive growth inNanomedicine Market is predicted to grow. It helps in understanding the key product segments and their future and helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments.

Reasons to Buy this Report

Gain detailed insights on theNanomedicine industry trends

Find complete analysis on the market status

Identify theNanomedicine market Counteropportunities and growth segments

Analyze competitive dynamics by evaluating business segments & product portfolios

Facilitate strategy planning and industry dynamics to enhance decision making

The report offers in-depth assessment of the growth and other aspects of theNanomedicine market in important countries (regions), including:

North America

Europe

Asia PacificCounter

Middle East & Africa

Latin America

America Country (United States, Canada)

South America

Asia Country (China, Japan, India, Korea)

Europe Country (Germany, UK, France, Italy)

Other Country (Middle East, Africa, GCC)

Get Complete TOCon this Premium Report, Click Here @

TABLE OF CONTENT

1 Report Overview

2 Global Growth Trends

3 Market Share by Key Players

4 Breakdown Data by Type and Application

5 United States

6 Europe

7 China

8 Japan

9 Southeast Asia

10 India

11 Central & South America

12 International Players Profiles

13 Market Forecast 2020-2027

14 Analysts Viewpoints/Conclusions

15 Appendix

About Author:

Market research is the new buzzword in the market, which helps in understanding the market potential of any product in the market. This helps in understanding the market players and the growth forecast of the products and so the company. This is where market research companies come into the picture. Reports And Markets is not just another company in this domain but is a part of a veteran group called Algoro Research Consultants Pvt. Ltd. It offers premium progressive statistical surveying, market research reports, analysis & forecast data for a wide range of sectors both for the government and private agencies all across the world.

Contact Us:

Sanjay Jain

Manager Partner Relations & International

https://www.reportsandmarkets.com/

Ph: +1-352-353-0818 (US)

Original post:
(IMPACT OF COVID-19) Nanomedicine Market Research 2020 Next Big Thing | GE Healthcare, Johnson& Johnson, Mallinckrodt plc, Merck& Co. Inc.,...

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine and drug delivery systems: The cutting edge of modern healthcare – Advanced Science News

Share

Share

Email

Nanomedicine and drug delivery systems are at the forefront of modern healthcare. These systems offer a new platform for drug delivery that can greatly increase the targeting and effectiveness of therapy.

Over the last twenty years, great strides have been made in cancer nanomedicine and tissue repair using targeted drug delivery systems. In this field, the goal is to take advantage of the unique properties of a material on the nanoscale to minimize toxicity in healthy organs by specifically targeting cancerous cells. Our research group has sought to develop safer and more efficacious therapies in order to advance patient care and clinical outcomes.

Concerning nanomedicine, the focus of our research has been to improve the treatment of different types of cancer, among them lymphoma and glioma. We have developed polymeric and lipid nanoparticles loaded with different antitumor agents, such as edelfosine, which presents the singular characteristic of not targeting the cells DNA but the cell membrane and the apoptotic machinery of the cancer cell. These nanosystems were able to cross the blood-brain barrier, and furthermore, in the case of lymphoma models, they were found to successfully inhibit not only the primary tumor, but also its spread to other parts of the body when administered orally.

More recently, our attention has been centered on the use of nanotechnology for the treatment of pediatric cancers, particularly osteosarcoma, which is the most frequently observed primary malignant bone tumor in the pediatric population. We have shown that our nanomedicines decreased the toxicity of the entrapped edelfosine, and that this treatment slowed the progression of the primary tumor growth in orthotopic osteosarocoma animal models, successfully preventing the metastatic spread of the osteosarcoma cells from the primary tumor to the lungs these findings were significant as it is assumed that 80% of patients with osteosarcoma present non-detectable micrometastases at diagnosis. The nanomedicines we have developed, and more specifically lipid based nanosystems entrapping edelfosine, could provide a more effective and safer alternative to conventional treatments for different types of cancers.

Regenerative medicine has also been of great interest to us. It is an interdisciplinary field that promotes regeneration of tissue or organs damaged by disease, which contrasts with traditional strategies that focus primarily on treating symptoms. In this sense, our focus has been the development of novel drug delivery systems to provide better treatment for brain and cardiac diseases. A large number of the projects carried out by our group have been done in collaboration with clinicians, pharmaceutical scientists, material engineers, and veterinarians, leading to novel delivery systems in key areas of unmet medical needs such as Parkinsons disease and myocardial infarction.

Specifically, our biomaterials can solve one of the greatest issues associated with biotherapeutic formulation and delivery, which is their fast degradation. In order to overcome this challenge, we have designed various microparticle-based technologies which we are able to protect biomolecules from degradation in biological environments. Our technique avoids shear stress and preserves the proteins from degradation during the manufacture process.

We have demonstrated that the injection of microparticles loaded with glial cell line-derived neurotrophic factor (GDNF) one of the most promising candidates for the treatment of Parkinsons disease within the brain of animals with severe nigrostriatal degeneration achieved long-term improvement in motor function, which was associated with the restoration of the dopaminergic function.

Similar to the positive results observed in the treatment of Parkinsons disease, we also observed improved cardiac recovery after myocardial infarction after treatment with neuregulin or fibroblast growth factor loaded microparticles. Interestingly, these microparticles modulated the inflammatory process towards a reparative response. However, we are only starting to obtain a glimpse into the crucial role of the inflammatory response for tissue repair. More studies addressing the contribution of different macrophage subsets to the reparative process are mandatory to fully understand the therapeutic potential of modulating the inflammatory response, as therapeutic treatment not only for myocardial infarction, but also for several other diseases, including cancer.

Beyond assessing the efficacy of microencapsulated biotherapeutics, microparticle optimization has also been a regular topic of discussion in the research group. The hydrophilic polymer coating, poly (ethylene glycol) (PEG), is well-known to increase the half-life of biotherapeutics and to reduce particle clearance in the blood, but the same strategy has not proven effective in reducing particle elimination in the heart. PEG decreases particle clearance in the blood by blocking opsonins, macromolecules that bind particles and mark them to be eliminated by phagocytes. However, in the cardiac tissue, particle clearance may not be dependent on opsonins which would explain why PEG failed to improve microparticle bioavailability in the heart.

Mirco- and nanoparticle-based drug delivery systems combined with cell therapy can achieve a more complete and potent regenerative response. Indeed, biomimetic biomaterials with tunable properties can be tailored to influence the fate of transplanted cells and to improve current cell delivery strategies. Within this framework, the use of microparticles as delivery vehicles for stem cells and human cardiomyocytes has proven to maximize the efficacy of cell therapy by dramatically enhancing cell survival in the heart. Cutting-edge areas such as non-invasive intravenous delivery of cardioprotective nanomedicines or extracellular vesicle-based therapies are also currently being explored.

Despite increased efforts made to improve current strategies in the above mentioned diseases, there are still aspects that limit the transfer of drug delivery systems to clinical practice, including the standardization of criteria and validated methods to characterize these novel systems of drug administration, large scale-manufacturing, the use of animal models that better simulate the pathophysiological aspects of the diseases and government regulations. An additional issue that could influence their clinical translation is the overall cost-effectiveness in comparison to current therapies.

In any case it is clear that the advances achieved in nanomedicine and drug delivery technologies offer huge potential for novel therapeutic approaches to unmet medical needs such as cancer, as well as cardiovascular and neurodegenerative diseases.

Written by: Mara Blanco-Prieto [1]

[1] Department of Pharmacy and Pharmaceutical Technology, Universidad de Navarra

Reference: Elisa Garbayo, et al. Nanomedicine and drug delivery systems in cancer and regenerative medicine. WIREs Nanomedicine and Nanobiotechnology (2020). DOI: 10.1002/wnan.1637

Read the original:
Nanomedicine and drug delivery systems: The cutting edge of modern healthcare - Advanced Science News

Recommendation and review posted by Alexandra Lee Anderson

Healthcare Nanotechnology (Nanomedicine) Market Share, Revenue, And Average Worth By Makers Shared In An Exceedingly Latest Analysis Report – Cole of…

The Healthcare Nanotechnology (Nanomedicine) market report [6 Years Forecast 2020-2026] focuses on the COVID19 Outbreak Impact analysis of key points influencing the growth of the market. Providing info like market competitive situation, product scope, market overview, opportunities, driving force and market risks. Profile the Top Key Players of Healthcare Nanotechnology (Nanomedicine), with sales, revenue and global market share of Healthcare Nanotechnology (Nanomedicine) are analyzed emphatically by landscape contrast and speak to info. Upstream raw materials and instrumentation and downstream demand analysis is additionally administrated. The Healthcare Nanotechnology (Nanomedicine) market business development trends and selling channels square measure analyzed. From a global perspective, It also represents overall industry size by analyzing qualitative insights and historical data.

The study encompasses profiles of major companies operating in the global Healthcare Nanotechnology (Nanomedicine) market. Key players profiled in the report includes : Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith&Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Shire, Ipsen, Endo International, and among others.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Healthcare Nanotechnology (Nanomedicine) Market @https://www.researchmoz.us/enquiry.php?type=S&repid2041239

The Healthcare Nanotechnology (Nanomedicine) market report provides a comprehensive analysis of:Industry overview, cost structure analysis, technical data and competitive analysis, topmost players analysis, development trend analysis, overall market overview, regional market analysis, consumers analysis and marketing type analysis.

Scope of Healthcare Nanotechnology (Nanomedicine) Market:

The global Healthcare Nanotechnology (Nanomedicine) market is valued at million US$ in 2019 and will reach million US$ by the end of 2026, growing at a CAGR of during 2020-2026. The objectives of this study are to define, segment, and project the size of the Healthcare Nanotechnology (Nanomedicine) market based on company, product type, application and key regions.

This report studies the global market size of Healthcare Nanotechnology (Nanomedicine) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Healthcare Nanotechnology (Nanomedicine) in these regions.

This research report categorizes the global Healthcare Nanotechnology (Nanomedicine) market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors, customers, research findings & conclusion, appendix & data source and Porters Five Forces Analysis.

The end users/applications and product categories analysis:

On the basis on the end users/applications,this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate foreach application.

On the basis of product,this report displays the sales volume, revenue (Million USD), product price, market share and growth rate ofeach type.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid2041239

(*Fill the form and our sales representative will get back to you for assistance)

Healthcare Nanotechnology (Nanomedicine) Market The Regional analysis covers:

Key Takeaways and Reasons To Buy Healthcare Nanotechnology (Nanomedicine) Market Report:

And Many More.Contact Us:

ResearchMozMr. Rohit Bhisey,Tel: +1-518-621-2074USA-Canada Toll Free: 866-997-4948Email: [emailprotected]Follow us on LinkedIn @ http://bit.ly/2RtaFUo

Follow me on : https://marketnews-24.blogspot.com/

See the rest here:
Healthcare Nanotechnology (Nanomedicine) Market Share, Revenue, And Average Worth By Makers Shared In An Exceedingly Latest Analysis Report - Cole of...

Recommendation and review posted by Alexandra Lee Anderson

Healthcare Nanotechnology (Nanomedicine) Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026 – Cole of Duty

Endo International

Moreover, the Healthcare Nanotechnology (Nanomedicine) report offers a detailed analysis of the competitive landscape in terms of regions and the major service providers are also highlighted along with attributes of the market overview, business strategies, financials, developments pertaining as well as the product portfolio of the Healthcare Nanotechnology (Nanomedicine) market. Likewise, this report comprises significant data about market segmentation on the basis of type, application, and regional landscape. The Healthcare Nanotechnology (Nanomedicine) market report also provides a brief analysis of the market opportunities and challenges faced by the leading service provides. This report is specially designed to know accurate market insights and market status.

By Regions:

* North America (The US, Canada, and Mexico)

* Europe (Germany, France, the UK, and Rest of the World)

* Asia Pacific (China, Japan, India, and Rest of Asia Pacific)

* Latin America (Brazil and Rest of Latin America.)

* Middle East & Africa (Saudi Arabia, the UAE, , South Africa, and Rest of Middle East & Africa)

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=210503&utm_source=NYH&utm_medium=888

Table of Content

1 Introduction of Healthcare Nanotechnology (Nanomedicine) Market

1.1 Overview of the Market1.2 Scope of Report1.3 Assumptions

2 Executive Summary

3 Research Methodology

3.1 Data Mining3.2 Validation3.3 Primary Interviews3.4 List of Data Sources

4 Healthcare Nanotechnology (Nanomedicine) Market Outlook

4.1 Overview4.2 Market Dynamics4.2.1 Drivers4.2.2 Restraints4.2.3 Opportunities4.3 Porters Five Force Model4.4 Value Chain Analysis

5 Healthcare Nanotechnology (Nanomedicine) Market, By Deployment Model

5.1 Overview

6 Healthcare Nanotechnology (Nanomedicine) Market, By Solution

6.1 Overview

7 Healthcare Nanotechnology (Nanomedicine) Market, By Vertical

7.1 Overview

8 Healthcare Nanotechnology (Nanomedicine) Market, By Geography

8.1 Overview8.2 North America8.2.1 U.S.8.2.2 Canada8.2.3 Mexico8.3 Europe8.3.1 Germany8.3.2 U.K.8.3.3 France8.3.4 Rest of Europe8.4 Asia Pacific8.4.1 China8.4.2 Japan8.4.3 India8.4.4 Rest of Asia Pacific8.5 Rest of the World8.5.1 Latin America8.5.2 Middle East

9 Healthcare Nanotechnology (Nanomedicine) Market Competitive Landscape

9.1 Overview9.2 Company Market Ranking9.3 Key Development Strategies

10 Company Profiles

10.1.1 Overview10.1.2 Financial Performance10.1.3 Product Outlook10.1.4 Key Developments

11 Appendix

11.1 Related Research

Get Complete Report

@ https://www.marketresearchintellect.com/need-customization/?rid=210503&utm_source=NYH&utm_medium=888

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Tags: Healthcare Nanotechnology (Nanomedicine) Market Size, Healthcare Nanotechnology (Nanomedicine) Market Trends, Healthcare Nanotechnology (Nanomedicine) Market Growth, Healthcare Nanotechnology (Nanomedicine) Market Forecast, Healthcare Nanotechnology (Nanomedicine) Market Analysis Sarkari result, Government Jobs, Sarkari naukri, NMK, Majhi Naukri,

Our Trending Reports

Fin Tech Blockchain Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Flexible Polyurethane Foam Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Continue reading here:
Healthcare Nanotechnology (Nanomedicine) Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026 - Cole of Duty

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026 – Cole of Duty

The research report on the Nanomedicine Market offers a comprehensive study on market share, size, growth aspects, and major players. In addition, the report contains brief information about the regional competitive landscape, market trends, and drivers, opportunities and challenges, distributors, sales channels, risks & entry barriers, as well as Porters Five Forces Analysis. Moreover, the main objective of this report is to offer a detailed analysis of how the market aspects potentially influence the coming future of the Nanomedicine market. The report also offers a comprehensive analysis about the competitive manufacturers as well as the new entrants also studies along with their brief research.

The report includes the latest coverage of the impact of COVID-19 on the Nanomedicine industry. The incidence has affected nearly every aspect of the business domain. This study evaluates the current scenario and predicts future outcomes of the pandemic on the global economy.

Get | Download Sample Copy of Nanomedicine Market Research Report @ https://www.marketresearchintellect.com/download-sample/?rid=201321&utm_source=NYH&utm_medium=888

In addition, this report also contains a price, revenue, market share, and production of the service providers is also mentioned with accurate data. Moreover, the global Nanomedicine report majorly focuses on the current developments, new possibilities, advancements, as well as dormant traps. Furthermore, the Nanomedicine market report offers a complete analysis of the current situation and the advancement possibilities of the Nanomedicine market across the globe. This report analyses substantial key components such as production, capacity, revenue, price, gross margin, sales revenue, sales volume, growth rate, consumption, import, export, technological developments, supply, and future growth strategies.

We provide a detailed analysis of key players operating in the Nanomedicine Market:

Moreover, the Nanomedicine report offers a detailed analysis of the competitive landscape in terms of regions and the major service providers are also highlighted along with attributes of the market overview, business strategies, financials, developments pertaining as well as the product portfolio of the Nanomedicine market. Likewise, this report comprises significant data about market segmentation on the basis of type, application, and regional landscape. The Nanomedicine market report also provides a brief analysis of the market opportunities and challenges faced by the leading service provides. This report is specially designed to know accurate market insights and market status.

By Regions:

* North America (The US, Canada, and Mexico)

* Europe (Germany, France, the UK, and Rest of the World)

* Asia Pacific (China, Japan, India, and Rest of Asia Pacific)

* Latin America (Brazil and Rest of Latin America.)

* Middle East & Africa (Saudi Arabia, the UAE, , South Africa, and Rest of Middle East & Africa)

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=201321&utm_source=NYH&utm_medium=888

Table of Content

1 Introduction of Nanomedicine Market

1.1 Overview of the Market1.2 Scope of Report1.3 Assumptions

2 Executive Summary

3 Research Methodology

3.1 Data Mining3.2 Validation3.3 Primary Interviews3.4 List of Data Sources

4 Nanomedicine Market Outlook

4.1 Overview4.2 Market Dynamics4.2.1 Drivers4.2.2 Restraints4.2.3 Opportunities4.3 Porters Five Force Model4.4 Value Chain Analysis

5 Nanomedicine Market, By Deployment Model

5.1 Overview

6 Nanomedicine Market, By Solution

6.1 Overview

7 Nanomedicine Market, By Vertical

7.1 Overview

8 Nanomedicine Market, By Geography

8.1 Overview8.2 North America8.2.1 U.S.8.2.2 Canada8.2.3 Mexico8.3 Europe8.3.1 Germany8.3.2 U.K.8.3.3 France8.3.4 Rest of Europe8.4 Asia Pacific8.4.1 China8.4.2 Japan8.4.3 India8.4.4 Rest of Asia Pacific8.5 Rest of the World8.5.1 Latin America8.5.2 Middle East

9 Nanomedicine Market Competitive Landscape

9.1 Overview9.2 Company Market Ranking9.3 Key Development Strategies

10 Company Profiles

10.1.1 Overview10.1.2 Financial Performance10.1.3 Product Outlook10.1.4 Key Developments

11 Appendix

11.1 Related Research

Get Complete Report

@ https://www.marketresearchintellect.com/need-customization/?rid=201321&utm_source=NYH&utm_medium=888

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Tags: Nanomedicine Market Size, Nanomedicine Market Trends, Nanomedicine Market Growth, Nanomedicine Market Forecast, Nanomedicine Market Analysis Sarkari result, Government Jobs, Sarkari naukri, NMK, Majhi Naukri,

Our Trending Reports

Double Piston Screen Changers Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Down-draught Gasifier Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Dozers Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

See more here:
Nanomedicine Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026 - Cole of Duty

Recommendation and review posted by Alexandra Lee Anderson

Nanobiotix: Publication of the 2019 Universal Registration Document – Business Wire

PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News:

NANOBIOTIX (Paris:NANO) (Euronext: NANO ISIN: FR0011341205 the Company), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the publication of its universal registration document for the financial year ended December 31, 2019. This document has been approved by the French financial market authority (Autorit des marchs financiers or AMF) on May 12, 2020 under the number R.20-010.

This document is available on Nanobiotixs website on https://www.nanobiotix.com/regulated-information/ and on the AMF website on (www.amf-france.org).

The 2019 universal registration document includes:

- the 2019 financial annual report,- the management report, including the information and the report on corporate governance,- The reports from the Companys statutory auditors and information related to their fees, and- The required information in relation to the Companys share buy-back program

About NANOBIOTIX: http://www.nanobiotix.com

Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell.

The Nanobiotix philosophy is rooted in designing pioneering, physical-based approaches to bring highly effective and generalized solutions to address unmet medical needs and challenges.

Nanobiotixs first-in-class, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Nanobiotixs Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.

Nanobiotix is listed on the regulated market of Euronext in Paris (Euronext: NANO / ISIN: FR0011341205; Bloomberg: NANO: FP). The Companys headquarters are in Paris, France with a U.S. affiliate in Cambridge, MA, and European affiliates in Spain and Germany. The Company also possesses an affiliate, Curadigm, located in Paris, France as well as, through an affiliate, in Cambridge, MA in the U.S.

DisclaimerThis press release contains certain forward-looking statements concerning Nanobiotix and its business, including its prospects and product candidate development. Such forward-looking statements are based on assumptions that Nanobiotix considers to be reasonable. However, there can be no assurance that the estimates contained in such forward-looking statements will be verified, which estimates are subject to numerous risks including the risks set forth in the universal registration document of Nanobiotix approved by the French Financial Markets Authority (Autorit des Marchs Financiers) under number R.20-018 on May 12, 2020 (a copy of which is available on http://www.nanobiotix.com) and to the development of economic conditions, financial markets and the markets in which Nanobiotix operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Nanobiotix or not currently considered material by Nanobiotix. The occurrence of all or part of such risks could cause actual results, financial conditions, performance or achievements of Nanobiotix to be materially different from such forward-looking statements.

Read more:
Nanobiotix: Publication of the 2019 Universal Registration Document - Business Wire

Recommendation and review posted by Alexandra Lee Anderson


Page 4«..3456..1020..»